Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lynn Chang

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Current Oncology (Toronto, Ont.)|January 20, 2022
Management Strategies for Older Patients with Low-Risk Early-Stage Breast Cancer: A Physician SurveyMashari Alzahrani, Mark Clemons, Lynn Chang, et al.
Journal of the American Academy of Dermatology|June 19, 2016
Update to an open-label clinical trial of vismodegib as neoadjuvant before surgery for high-risk basal cell carcinoma (BCC)Gina P Kwon, Mina Sarah Ally, Irene Bailey-Healy, et al.
Breast (Edinburgh, Scotland)|February 24, 2023
Long-term outcomes and effects of hypofractionated radiotherapy in microinvasive breast cancer: Analysis from a randomized trialMira Goldberg, Sameer Parpia, Eileen Rakovitch, et al.
Scandinavian Journal of Immunology|June 27, 2019
Characterization of lymphatic malformations using primary cells and tissue transcriptomesArja Kaipainen, Emy Chen, Lynn Chang, et al.
Journal of the American Academy of Dermatology|June 16, 2014
An investigator-initiated open-label clinical trial of vismodegib as a neoadjuvant to surgery for high-risk basal cell carcinomaMina Sarah Ally, Sumaira Aasi, Ashley Wysong, et al.
Journal of Drugs in Dermatology : JDD|September 4, 2024
Novel Strategy for Strengthening Dermatoporotic Skin by Managing Cellular SenescenceAlan D Widgerow, Mary Ziegler, John A Garruto, et al.
JAMA Surgery|September 14, 2022
Same-Day Home Recovery for Benign Foregut SurgerySwee H Teh, Samuel C Schecter, Edgar B Servais, et al.
Current Oncology (Toronto, Ont.)|December 23, 2021
Experiences and Perceptions of Older Adults with Lower-Risk Hormone Receptor-Positive Breast Cancer about Adjuvant Radiotherapy and Endocrine Therapy: A Patient SurveyMarie-France Savard, Mashari Jemaan Alzahrani, Deanna Saunders, et al.
Cancer Treatment Reviews|July 9, 2021
De-escalating adjuvant therapies in older patients with lower risk estrogen receptor-positive breast cancer treated with breast-conserving surgery: A systematic review and meta-analysisMarie-France Savard, Mark Clemons, Brian Hutton, et al.
The New England Journal of Medicine|August 16, 2023
Omitting Radiotherapy after Breast-Conserving Surgery in Luminal A Breast CancerTimothy J Whelan, Sally Smith, Sameer Parpia, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Current Oncology (Toronto, Ont.)|January 20, 2022
Management Strategies for Older Patients with Low-Risk Early-Stage Breast Cancer: A Physician SurveyMashari Alzahrani, Mark Clemons, Lynn Chang, et al.
Journal of the American Academy of Dermatology|June 19, 2016
Update to an open-label clinical trial of vismodegib as neoadjuvant before surgery for high-risk basal cell carcinoma (BCC)Gina P Kwon, Mina Sarah Ally, Irene Bailey-Healy, et al.
Breast (Edinburgh, Scotland)|February 24, 2023
Long-term outcomes and effects of hypofractionated radiotherapy in microinvasive breast cancer: Analysis from a randomized trialMira Goldberg, Sameer Parpia, Eileen Rakovitch, et al.
Scandinavian Journal of Immunology|June 27, 2019
Characterization of lymphatic malformations using primary cells and tissue transcriptomesArja Kaipainen, Emy Chen, Lynn Chang, et al.
Journal of the American Academy of Dermatology|June 16, 2014
An investigator-initiated open-label clinical trial of vismodegib as a neoadjuvant to surgery for high-risk basal cell carcinomaMina Sarah Ally, Sumaira Aasi, Ashley Wysong, et al.
Journal of Drugs in Dermatology : JDD|September 4, 2024
Novel Strategy for Strengthening Dermatoporotic Skin by Managing Cellular SenescenceAlan D Widgerow, Mary Ziegler, John A Garruto, et al.
JAMA Surgery|September 14, 2022
Same-Day Home Recovery for Benign Foregut SurgerySwee H Teh, Samuel C Schecter, Edgar B Servais, et al.
Current Oncology (Toronto, Ont.)|December 23, 2021
Experiences and Perceptions of Older Adults with Lower-Risk Hormone Receptor-Positive Breast Cancer about Adjuvant Radiotherapy and Endocrine Therapy: A Patient SurveyMarie-France Savard, Mashari Jemaan Alzahrani, Deanna Saunders, et al.
Cancer Treatment Reviews|July 9, 2021
De-escalating adjuvant therapies in older patients with lower risk estrogen receptor-positive breast cancer treated with breast-conserving surgery: A systematic review and meta-analysisMarie-France Savard, Mark Clemons, Brian Hutton, et al.
The New England Journal of Medicine|August 16, 2023
Omitting Radiotherapy after Breast-Conserving Surgery in Luminal A Breast CancerTimothy J Whelan, Sally Smith, Sameer Parpia, et al.
Pageof 3